Comparison of the effectiveness of botulinum toxin, dry needling, pharmacological treatment, and manual therapy for bruxism-induced myalgia: a prospective randomized study

Bruxism is a significant phenomenon that should not be underestimated, given its prevalence and consequences. The major symptoms associated with bruxism include myalgia, decreased quality of life, and limited mandibular movements. This study aimed to evaluate and compare the effectiveness of four treatment methods for managing bruxism-related symptoms: botulinum toxin (BoNT-A), dry needling (DN), pharmacological therapy (PT), and manual therapy (MT). Eighty patients with bruxism (44 female, 36 male) were randomly assigned to four groups of 20 patients each. All therapies were administered by the same maxillofacial surgeon. Measurements were recorded at baseline (pre-treatment) and at 2, 4 and 12 weeks post-treatment. The metrics assessed included the visual analog scale (VAS) for pain, maximum painless mouth opening (MMO), and the Oral Health Impact Profile-14 (OHIP-14) questionnaire. Statistical analysis was performed using a mixed-design repeated measures two-way analysis of variance (ANOVA) to compare changes within and among the groups over time. Tukey’s multiple comparison test was applied for further analysis. The results indicated that both objective and subjective clinical outcomes were similar across all treatment groups. Considering their competitive efficiency, non-invasiveness or minimal invasiveness, and cost-effectiveness, DN, MT and PT appear to be promising alternatives for managing bruxism and its symptoms, especially in the early stages. ClinicalTrials ID: NCT06583551.

Botulinum toxin; Bruxism; Dry needling; Emotional stress; Exercise therapy; Myalgia

[1] Nykänen L, Manfredini D, Lobbezoo F, Kämppi A, Bracci A, Ahlberg J. Assessment of awake bruxism by a novel bruxism screener and ecological momentary assessment among patients with masticatory muscle myalgia and healthy controls. Journal of Oral Rehabilitation. 2024; 51: 162–169.

[2] Zieliński G, Pająk A, Wójcicki M. Global prevalence of sleep bruxism and awake bruxism in pediatric and adult populations: a systematic review and meta-analysis. Journal of Clinical Medicine. 2024; 13: 4259.

[3] Buzatu R, Luca MM, Castiglione L, Sinescu C. Efficacy and safety of botulinum toxin in the management of temporomandibular symptoms associated with sleep bruxism: a systematic review. Dentistry Journal. 2024; 12: 156.

[4] Yıldırım B, Kırarslan Karagoz O, Tekeli Simsek A, Koca C, Cicek MF. Associations between self-reported bruxism, sleep quality, and psychological status among dental students in Turkey. CRANIO®. 2024; 42: 63–68.

[5] von Piekartz H, Bleiss S, Herzer S, Hall T, Ballenberger N. Does combining oro-facial manual therapy with bruxism neuroscience education affect pain and function in cases of awake bruxism? A pilot study. Journal of Oral Rehabilitation. 2024; 51: 1692–1700.

[6] Memon AB, Rahman AAU, Channar KA, Zafar MS, Kumar N. Evaluating the oral-health-related quality of life of oral submucous fibrosis patients before and after treatment using the OHIP-14 tool. International Journal of Environmental Research and Public Health. 2022; 19: 1821.

[7] Savla K, Vardhan GD, Aage D. Physiotherapy in bruxism: a scoping review. International Journal of Health Sciences and Research. 2021; 11: 115–125.

[8] Ângelo DF, Mota B, João RS, Sanz D, Cardoso HJ. Prevalence of clinical signs and symptoms of temporomandibular joint disorders registered in the eurotmj database: a prospective study in a portuguese center. Journal of Clinical Medicine. 2023; 12: 3553.

[9] Lal SJ, Sankari A, Weber DDS KK. Bruxism management. StatPearls Publishing: Treasure Island (FL). 2024.

[10] Brand Kanters ART, Steenen SA, Gilden J, Khan M. Behandeling van bruxismegeïnduceerde masseterhypertrofie, tendomyalgie en attritie met botulinetoxine. Nederlands Tijdschrift Voor Tandheelkunde. 2023; 130: 525–529.

[11] Minakuchi H, Fujisawa M, Abe Y, Iida T, Oki K, Okura K, et al. Managements of sleep bruxism in adult: a systematic review. Japanese Dental Science Review. 2022; 58: 124–136.

[12] Porporatti AL, Costa YM, Réus JC, Stuginski-Barbosa J, Conti PCR, Velly AM, et al. Placebo and nocebo response magnitude on temporomandibular disorder-related pain: a systematic review and meta-analysis. Journal of Oral Rehabilitation. 2019; 46: 862–882.

[13] M Alwayli H, Abdulrahman BI, Rastogi S. Does botulinum toxin have any role in the management of chronic pain associated with bruxism? CRANIO®. 2024; 42: 215–222.

[14] Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. CRANIO®. 2008; 26: 126–135.

[15] Ågren M, Nanchaipruek Y, Phumariyapong P, Apinuntham C, Rakchart S, Pettersson M, et al. Duration of bite force reduction following a single injection of botulinum toxin in the masseter muscle bilaterally: a one-year non-randomized trial. Journal of Oral Rehabilitation. 2023; 50: 343–350.

[16] Soares-Silva L, de Amorim CS, Magno MB, Tavares-Silva C, Maia LC. Effects of different interventions on bruxism: an overview of systematic reviews. Sleep and Breathing. 2024; 28: 1465–1476.

[17] Ainoosah S, Farghal AE, Alzemei MS, Saini RS, Gurumurthy V, Quadri SA, et al. Comparative analysis of different types of occlusal splints for the management of sleep bruxism: a systematic review. BMC Oral Health. 2024; 24: 29.

[18] Kaya DI, Ataoglu H. Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: a prospective and randomized clinical study. Nigerian Journal of Clinical Practice. 2021; 24: 412–417.

[19] de Souza Nobre BB, Rezende L, Barbosa Câmara-Souza M, Sanchez-Ayala A, Blass R, Carbone AC, et al. Exploring botulinum toxin’s impact on masseter hypertrophy: a randomized, triple-blinded clinical trial. Scientific Reports. 2024; 14: 14522.

[20] Chen Y, Tsai CH, Bae TH, Huang CY, Chen C, Kang YN, et al. Effectiveness of botulinum toxin ınjection on bruxism: a systematic review and meta-analysis of randomized controlled trials. Aesthetic Plastic Surgery. 2023; 47: 775–790.

[21] Dib-Zakkour J, Flores-Fraile J, Montero-Martin J, Dib-Zakkour S, Dib-Zaitun I. Evaluation of the effectiveness of dry needling in the treatment of myogenous temporomandibular joint disorders. Medicina. 2022; 58: 256.

[22] Chmielewska D, Malá J, Opala-Berdzik A, Nocuń M, Dolibog P, Dolibog PT, et al. Acupuncture and dry needling for physical therapy of scar: a systematic review. BMC Complementary Medicine and Therapies. 2024; 24: 14.

[23] Ferreira CCQ, Lima KR, Dias-Peixoto MF, Orlando DR, Castelo PM, Pereira LJ, et al. Manual therapy and dry needling improve mobility, pain and reduce fear of COVID-19 in temporomandibular disorder patients: randomized controlled trial. Journal of Bodywork and Movement Therapies. 2024; 40: 620–626.

[24] Sheldon A, Karas S. Adverse events associated with manual therapy of peripheral joints: a scoping review. Journal of Bodywork and Movement Therapies. 2022; 31: 159–163.

[25] Menéndez-Torre Á, Pintado-Zugasti AM, Zaldivar JNC, García-Bermejo P, Gómez-Costa D, Molina-Álvarez M, et al. Effectiveness of deep dry needling versus manual therapy in the treatment of myofascial temporomandibular disorders: a systematic review and network meta-analysis. Chiropractic & Manual Therapies. 2023; 31: 46.

[26] Malcangi G, Patano A, Pezzolla C, Riccaldo L, Mancini A, Di Pede C, et al. Bruxism and botulinum injection: challenges and insights. Journal of Clinical Medicine. 2023; 12: 4586.

[27] Ayala JC, Rizzatti-Barbosa CM, Custodio W. Influence of botulinum toxin A in pain perception and condyle-fossa relationship after the management of temporomandibular dysfunction: a randomized controlled clinical trial. Oral and Maxillofacial Surgery. 2024; 28: 269–277.

[28] Jadhao VA, Lokhande N, Habbu SG, Sewane S, Dongare S, Goyal N. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism. Indian Journal of Dental Research. 2017; 28: 493–497.

[29] Fernández-Carnero J, La Touche R, Ortega-Santiago R, Galan-del-Rio F, Pesquera J, Ge HY, et al. Short-term effects of dry needling of active myofascial trigger points in the masseter muscle in patients with temporomandibular disorders. Journal of Oral & Facial Pain and Headache. 2010; 24: 106–112.

[30] Pintado MR, Anderson GC, DeLong R, Douglas WH. Variation in tooth wear in young adults over a two-year period. Journal of Prosthetic Dentistry. 1997; 77: 313–320.

[31] American Academy of Sleep Medicine. International classification of sleep disorders. 3rd edn. American Academy of Sleep Medicine: Darien, IL. 2014.

[32] Unverzagt C, Berglund K, Thomas JJ. Dry needling for myofascial trigger point pain: a clinical commentary. International Journal of Sports Physical Therapy. 2015; 10: 402–418.

[33] Grillo CM, Canales Gde L, Wada RS, Alves MC, Barbosa CM, Berzin F, et al. Could acupuncture be useful in the treatment of temporomandibular dysfunction? Journal of Acupuncture and Meridian Studies. 2015; 8: 192–199.

[34] Wu Y, Zeng D, Wu S. Botulinum toxin type a for the treatment of masseter muscle prominence in Asian populations. Aesthetic Surgery Journal Open Forum. 2023; 5: ojad005.

[35] Başol ME, Karaağaçlıoğlu L, Yılmaz B. Developing a Turkish Oral Health Impact Profile-OHIP-14-TR. Journal of Dental Sciences. 2014; 20: 85–92. (In Turkish)

[36] De la Torre Canales G, Poluha RL, Pinzón NA, Da Silva BR, Almeida AM, Ernberg M, et al. Efficacy of botulinum toxin type-a i in the improvement of mandibular motion and muscle sensibility in myofascial pain TMD subjects: a randomized controlled trial. Toxins. 2022; 14: 441.

[37] Blasco-Bonora PM, Martín-Pintado-Zugasti A. Effects of myofascial trigger point dry needling in patients with sleep bruxism and temporomandibular disorders: a prospective case series. Acupuncture in Medicine. 2017; 35: 69–74.

[38] Arnoni V, Righetti M, Silva N, Bombonato-Prado K, Regalo I, Vasconcelos PB, et al. Dry needling for treatment of temporomandibular disorder of muscular origin: a functional approach to the stomatognathic system. Acta Scientific Dental Sciences. 2023; 7: 84–90.

[39] González-Perez LM, Infante-Cossio P, Granados-Nunez M, Urresti-Lopez FJ, Lopez-Martos R, Ruiz-Canela-Mendez P. Deep dry needling of trigger points located in the lateral pterygoid muscle: efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction. Med Oral Patol Oral Cir Bucal. 2015; 20: e326–e333.

[40] Smith AR Jr. Manual therapy: the historical, current, and future role in the treatment of pain. The Scientific World Journal. 2007; 7: 109–120.

[41] Guarda-Nardini L, Stecco A, Stecco C, Masiero S, Manfredini D. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique. CRANIO®. 2012; 30: 95–102.

[42] De Laat A, Stappaerts K, Papy S. Counseling and physical therapy as treatment for myofascial pain of the masticatory system. Journal of Oral & Facial Pain and Headache. 2003; 17: 42–49.

[43] Gouw S, de Wijer A, Kalaykova SI, Creugers NHJ. Masticatory muscle stretching for the management of sleep bruxism: a randomised controlled trial. Journal of Oral Rehabilitation. 2018; 45: 770–776.

[44] Navarro-Santana MJ, Valera-Calero JA, Romanos-Castillo G, Hernández-González VC, Fernández-de-Las-Peñas C, López-de-Uralde-Villanueva I, et al. Immediate effects of dry needling on central pain processing and skin conductance in patients with chronic nonspecific neck pain: a randomized controlled trial. Journal of Clinical Medicine. 2022; 11: 6616.

[45] Armijo-Olivo S, Pitance L, Singh V, Neto F, Thie N, Michelotti A. Effectiveness of manual therapy and therapeutic exercise for temporomandibular disorders: systematic review and meta-analysis. Physical Therapy. 2016; 96: 9–25.

[46] Rayegani SM, Bayat M, Bahrami MH, Raeissadat SA, Kargozar E. Comparison of dry needling and physiotherapy in treatment of myofascial pain syndrome. Clinical Rheumatology. 2014; 33: 859–864.

[47] Yıldırım G, Erol F, Güven MC, Şakar O. Evaluation of the effects of bruxism on oral health-related quality of life in adults. CRANIO®. 2023; 41: 230–237.

[48] Zhu M, Huang Z, Wang Y, Qin J, Fan M. Effects of botulinum toxin type A in patients with painful temporomandibular joint disorders: a systematic review and meta-analysis. Annals of Medicine and Surgery. 2024; 86: 4112–4122.

[49] Boyce D, Wempe H, Campbell C, Fuehne S, Zylstra E, Smith G. Adverse events assocıated with therapeutic dry needling. International Journal of Sports Physical Therapy. 2020; 15: 103–113.

[50] Junior PR, Siéssere S, de Mello EC, Rodrigues S, Regalo I, Gonçalves LM, et al. Effect of dry needling and instrumental myofascial release on masticatory, facial, and cervical muscles of patients with temporomandibular disorders of muscular origin. Journal of Clinical and Experimental Dentistry. 2023; 15: e366–e375.

[51] Paanalahti K, Holm LW, Nordin M, Asker M, Lyander J, Skillgate E. Adverse events after manual therapy among patients seeking care for neck and/or back pain: a randomized controlled trial. BMC Musculoskeletal Disorders. 2014; 15: 77.

[52] Mesko ME, Hutton B, Skupien JA, Sarkis-Onofre R, Moher D, Pereira-Cenci T. Therapies for bruxism: a systematic review and network meta-analysis (protocol). Systematic Reviews. 2017; 6: 4.

[53] Nykänen L, Lobbezoo F, Kämppi A, Manfredini D, Ahlberg J. Awake bruxism in temporomandibular disorders patients referred to tertiary care: a retrospective study on its assessment and TMD management. Journal of Oral Rehabilitation. 2024; 51: 181–187.

[54] Manfredini D, Winocur E, Guarda-Nardini L, Lobbezoo F. Self-reported bruxism and temporomandibular disorders: findings from two specialised centres. Journal of Oral Rehabiitation. 2012; 39: 319–325.

[55] Aggarwal R, Ranganathan P. Study designs: part 4—Interventional studies. Perspectives in Clinical Research. 2019; 10: 137–139.

[56] Frisaldi E, Shaibani A, Benedetti F, Pagnini F. Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review. BMJ Open. 2023; 13: e077243.

[57] Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. The Cochrane Database of Systematic Reviews. 2010; 2010: CD003974.